We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of Eye Movement Testing and Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00472485
Recruitment Status : Completed
First Posted : May 11, 2007
Last Update Posted : July 3, 2008
Information provided by:
Ohio State University

Brief Summary:
The purpose of this study is to determine the ability of several eye movement monitors, used in clinical practice, to identify children with poor reading eye movements. A second purpose of the study is to evaluate the effectiveness of eye movement therapy.

Condition or disease Intervention/treatment
Saccadic Eye Movement Deficiency Oculomotor Deficiency Oculomotor Dysfunction Procedure: eye movement therapy

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Allocation: Non-Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Eye Care
U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   8 Years to 13 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Children ages 8 to 13 with saccadic eye movement deficit

Exclusion Criteria:

  • Previous saccadic eye movement therapy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00472485

United States, Ohio
The Ohio State University
Columbus, Ohio, United States, 43210
Sponsors and Collaborators
Ohio State University
Principal Investigator: Marjean Kulp, OD, MS Ohio State University

ClinicalTrials.gov Identifier: NCT00472485     History of Changes
Other Study ID Numbers: 00H0185
First Posted: May 11, 2007    Key Record Dates
Last Update Posted: July 3, 2008
Last Verified: July 2008